Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Shukla

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2024
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, Haitao Wang, Lyuba Varticovski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S Reardon, Vivek Shukla, Sichuan Xi, et al.
Neonatology|December 4, 2023
Neonatal Respiratory Support Utilization in Low- and Middle-Income Countries: A Registry-Based Observational StudyNora Switchenko, Vivek Shukla, Musaku Mwenechanya, et al.
Cancer Research|September 23, 2017
ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung CancerVivek Shukla, Mahadev Rao, Hongen Zhang, et al.
Hepatology (Baltimore, Md.)|January 24, 2017
Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instabilityJian Chen, Vivek Shukla, Patrizia Farci, et al.
Molecular Cancer Therapeutics|June 24, 2018
Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal AdenocarcinomaPaul L Feingold, Deborah R Surman, Kate Brown, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2024
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, Haitao Wang, Lyuba Varticovski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S Reardon, Vivek Shukla, Sichuan Xi, et al.
Neonatology|December 4, 2023
Neonatal Respiratory Support Utilization in Low- and Middle-Income Countries: A Registry-Based Observational StudyNora Switchenko, Vivek Shukla, Musaku Mwenechanya, et al.
Cancer Research|September 23, 2017
ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung CancerVivek Shukla, Mahadev Rao, Hongen Zhang, et al.
Hepatology (Baltimore, Md.)|January 24, 2017
Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instabilityJian Chen, Vivek Shukla, Patrizia Farci, et al.
Molecular Cancer Therapeutics|June 24, 2018
Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal AdenocarcinomaPaul L Feingold, Deborah R Surman, Kate Brown, et al.
Pageof 5